Details of the Drug Reposition

General Information of This Drug (ID: DMHTNLJ)

• Drug Name: CD7.CAR/28zeta CAR T cells (DMHTNLJ)
• Drug Type: CAR T Cell Therapy

Information on Drug Reposition of This Drug

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Cutaneous T-cell lymphoma	DISAYSZB	2B01	Phase 1	[1]
Non-hodgkin lymphoma	DISS2Y8A	2B33.5	Phase 1	[1]

References

• [1] ClinicalTrials.gov (NCT03690011) Cell Therapy for High Risk T-Cell Malignancies Using CD7-Specific CAR Expressed On Autologous T Cells